Chengdu Kanghong Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000020C4
CNY
29.00
0.91 (3.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,170.20
1,254.92
1,198.74
1,041.36
1,117.16
1,201.35
1,079.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,170.20
1,254.92
1,198.74
1,041.36
1,117.16
1,201.35
1,079.58
Raw Material Cost
103.77
152.96
156.67
146.18
136.26
150.87
146.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
595.30
599.26
506.06
467.49
522.07
585.78
463.80
Other Expenses
11.95
11.46
8.86
23.14
14.32
11.71
5.20
Total Expenditure (Excl Depreciation)
818.62
866.86
751.37
845.11
801.50
853.80
662.27
Operating Profit (PBDIT) excl Other Income
351.59999999999997
388.1
447.40000000000003
196.29999999999998
315.7
347.59999999999997
417.29999999999995
Other Income
16.11
22.19
29.30
36.35
17.36
43.53
28.45
Operating Profit (PBDIT)
355.06
450.00
523.23
273.19
380.40
430.71
503.87
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
1.16
-0.92
-0.96
0.33
-0.42
-1.24
0.27
Gross Profit (PBDT)
1,066.43
1,101.96
1,042.07
895.19
980.91
1,050.48
933.07
Depreciation
0.00
59.32
59.32
59.02
59.02
58.11
58.11
Profit Before Tax
356.23
389.75
462.94
214.50
320.97
371.37
446.03
Tax
56.73
64.42
66.18
2.25
42.52
56.26
74.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
303.21
329.68
400.02
217.52
281.49
318.70
373.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
303.21
329.68
400.02
217.52
281.49
318.70
373.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.95
-4.44
-3.39
-5.40
-3.14
-3.64
-2.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
299.26
325.24
396.62
212.12
278.35
315.06
371.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
9,166.36
8,862.97
9,054.67
8,653.20
8,435.51
8,153.76
8,177.53
Earnings per share (EPS)
0.33
0.36
0.43
0.24
0.31
0.35
0.41
Diluted Earnings per share
0.33
0.36
0.43
0.24
0.31
0.35
0.41
Operating Profit Margin (Excl OI)
28.97%
29.36%
36.25%
17.08%
27.21%
27.39%
38.66%
Gross Profit Margin
30.44%
35.79%
43.57%
26.27%
34.01%
35.75%
46.7%
PAT Margin
25.91%
26.27%
33.37%
20.89%
25.2%
26.53%
34.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -6.75% vs 4.69% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -7.96% vs -18.00% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -20.76% vs -13.38% in Jun 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Chengdu Kanghong Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,170.20
0
1,170.20
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,170.20
0
1,170.20
Raw Material Cost
103.77
0
103.77
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
595.30
0
595.30
Other Expenses
11.95
0.00
11.95
Total Expenditure (Excl Depreciation)
818.62
0
818.62
Operating Profit (PBDIT) excl Other Income
351.59
0.00
351.59
Other Income
16.11
0
16.11
Operating Profit (PBDIT)
355.06
0
355.06
Interest
0.00
0
0.00
Exceptional Items
1.16
0
1.16
Gross Profit (PBDT)
1,066.43
0
1,066.43
Depreciation
0.00
0
0.00
Profit Before Tax
356.23
0
356.23
Tax
56.73
0
56.73
Provisions and contingencies
0
0
0.00
Profit After Tax
303.21
0
303.21
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
303.21
0
303.21
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.95
0
-3.95
Other related items
0.00
0.00
0.00
Consolidated Net Profit
299.26
0
299.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
9,166.36
0
9,166.36
Earnings per share (EPS)
0.33
0
0.33
Diluted Earnings per share
0.33
0
0.33
Operating Profit Margin (Excl OI)
28.97%
0%
0.00
28.97%
Gross Profit Margin
30.44%
0%
0.00
30.44%
PAT Margin
25.91%
0%
0.00
25.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 117.02 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -6.75% vs 4.69% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 4.74% vs 3.60% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 29.93 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.96% vs -18.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 7.51% vs -6.10% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.90 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -20.76% vs -13.38% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -6.61% vs -7.59% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.97%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024